• Integrative Doctor

NAD+ could help treat COVID-19 patients, scientists say.

Nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme that is central to cellular metabolism.

NAD+ acts as a catalyst in the processing of nutrients and is essential in converting nutrients to energy, as well as modulating immune response to viral infections.

Scientists in Bahrain have published a paper stating that COVID-19 infection can result in reduced NAD+ levels in our cells, and that restoring NAD+ levels could be an important treatment for patients with the illness.

NAD+ levels are known to diminish with age, which can reduce the effectiveness of the body’s immune response. Death rates from COVID-19 increase with age.

One possible reason for the depletion of NAD+ in COVID-19 patients is related to a large protein called poly-ADP ribose polymerase-1 (PARP-1). PARP-1 helps catalyse the breakdown of NAD+ to perform its antiviral work, but the SARS-CoV-2 virus that causes COIVD-19 inhibits its effectiveness, leading to excessive PARP-1 activation and an inflammatory response.

This leads to increased consumption of NAD+, inhibiting cellular energy and resulting in cell death.

Writing in the Journal of Infection and Public Health, the Bahrain researchers suggest that restoring normal NAD+ levels in older COVID-19 patients could decrease the severity of their immune response and improve their overall health condition.

At PIM we have a particular interest in the role of micronutrients in our health and wellbeing. Contact us to learn more.

Click here to read more detail about the research.

79 views0 comments

Recent Posts

See All